Northwest Biotherapeutics, Inc.
NWBO
$0.17
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.21% | -35.73% | 39.77% | 55.15% | 49.81% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.61% | 131.57% | 14.79% | 3.28% | -12.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.18% | 32.35% | 35.82% | 38.64% | 23.69% |
|
|
|||||
| Total Current Assets | -58.18% | 32.35% | 35.82% | 38.64% | 23.69% |
| Net Property, Plant & Equipment | -3.08% | 1.40% | 5.99% | -3.21% | 0.69% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 3,919.50% | 3,928.48% | 4,016.72% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.32% | -3.54% | -2.47% | -4.28% | -0.54% |
| Total Assets | 157.02% | 191.04% | 204.14% | 4.39% | 4.68% |
|
|
|||||
| Total Accounts Payable | 37.49% | 52.22% | 81.60% | 50.03% | 56.24% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -37.19% | -40.69% | -33.26% | 79.09% | 83.68% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.41% | 28.50% | 61.16% | 26.86% | 18.43% |
| Total Finance Division Other Current Liabilities | -60.67% | -55.86% | 51.03% | 60.43% | 75.73% |
| Total Other Current Liabilities | -60.67% | -55.86% | 51.03% | 60.43% | 75.73% |
| Total Current Liabilities | -12.59% | -0.10% | 34.31% | 47.58% | 49.39% |
|
|
|||||
| Total Current Liabilities | -12.59% | -0.10% | 34.31% | 47.58% | 49.39% |
| Long-Term Debt | -19.58% | -19.40% | -36.82% | 29.98% | 12.25% |
| Short-term Debt | -37.19% | -40.69% | -33.26% | 79.09% | 83.68% |
| Capital Leases | -7.96% | -4.03% | -0.61% | -7.89% | 6.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 211.96% | 211.40% | 216.40% | -63.83% | -6.00% |
| Total Liabilities | -4.70% | 5.13% | 21.90% | 34.52% | 35.15% |
|
|
|||||
| Common Stock & APIC | 6.62% | 6.95% | 7.31% | 4.68% | 4.74% |
| Retained Earnings | -2.55% | -3.00% | -4.17% | -6.34% | -5.90% |
| Treasury Stock & Other | 82.52% | -139.39% | -134.28% | -1,100.00% | -189.88% |
| Total Common Equity | 55.00% | 49.19% | 36.20% | -35.61% | -31.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -24.39% | -14.73% | -18.04% | -15.60% | -26.66% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -24.39% | -14.73% | -18.04% | -15.60% | -26.66% |
|
|
|||||
| Total Common Equity | 55.00% | 49.19% | 36.20% | -35.61% | -31.23% |
| Total Preferred Equity | -24.39% | -14.73% | -18.04% | -15.60% | -26.66% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.86% | 55.14% | 39.77% | -48.27% | -50.03% |
|
|
|||||